Business Chronic Lower Back Pain Market Insight, Epidemiology And Market Forecast 2032 ByHaven smith July 5, 2022
Business Is there enough opportunity in the competitive therapeutic landscape of Multiple Myeloma for new CAR-T cell therapies? ByHaven smith July 4, 2022
Business AbbVie’s Telisotuzumab Vedotin (Teliso-V) Demonstrated Encouraging Responses In C-MET NSCLC Patients Who Progressed On Previous Treatments ByHaven smith July 1, 2022
Business Daiichi’s novel HER3 ADC has Shown To Have a Spark in HER3 NSCLC, post success in the HER3 Breast Cancer Trial ByHaven smith June 30, 2022
Business Treatment resistant depression Market Insight, Epidemiology And Market Forecast 2032 ByHaven smith June 30, 2022
Business Junshi’s domestic Toripalimab’s significant results in recurrent or metastatic HNSCC. CRL issued on Nasopharyngeal Carcinoma could prove to be a setback? ByHaven smith June 29, 2022
Business Sermonix’s Lasofoxifene, a potent oral SERM, emerges as a critical player in ESR1 mutated advanced HR+ breast cancer ByHaven smith June 28, 2022
Business Nasal Polyposis Market Insight, Epidemiology And Market Forecast 2032 ByHaven smith June 28, 2022
Business Mimivax’s SurVaxM Improves Survival Time In Newly Diagnosed Glioblastoma ByHaven smith June 27, 2022
